Overview
Helicobacter Pylori Treatment in Immune Thrombocytopenic Purpura (ITP) Patients
Status:
Completed
Completed
Trial end date:
2012-03-01
2012-03-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to determine whether eradication of Helicobacter pylori infection is effective in the improvement of platelet counts in children and adolescents with chronic ITP.Phase:
Phase 2/Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Federal University of São PauloCollaborator:
Fundação de Amparo à Pesquisa do Estado de São PauloTreatments:
Clarithromycin
Furazolidone
Criteria
Inclusion Criteria:- clinical diagnosis of chronic immune thrombocytopenic purpura
- children and adolescents up to 20 years
Exclusion Criteria:
- known hypersensitivity to any of the drugs
- recent treatment for H. pylori eradication